{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T20:45:49Z","timestamp":1749501949780,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12029-020-00536-3","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T04:12:57Z","timestamp":1602648777000},"page":"1029-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma"],"prefix":"10.1007","volume":"52","author":[{"given":"Gayatri","family":"Behera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvradeep","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar S","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-5540","authenticated-orcid":false,"given":"Suvendu","family":"Purkait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"2","key":"536_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102.","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"536_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40880-017-0252-1","volume":"36","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer. Chin J Cancer. 2017;36(1):85.","journal-title":"Chin J Cancer"},{"issue":"7330","key":"536_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343\u20139.","journal-title":"Nature"},{"issue":"24","key":"536_CR4","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/sj.onc.1204341","volume":"20","author":"KD Robertson","year":"2001","unstructured":"Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene. 2001;20(24):3139\u201355.","journal-title":"Oncogene"},{"issue":"20","key":"536_CR5","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1933744100","volume":"100","author":"CG Kleer","year":"2003","unstructured":"Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003;100(20):11606\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24 Pt 1","key":"536_CR6","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1158\/1078-0432.CCR-05-1047","volume":"11","author":"JD Raman","year":"2005","unstructured":"Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res. 2005;11(24 Pt 1):8570\u20136.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"536_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.humpath.2010.03.004","volume":"41","author":"AD Toll","year":"2010","unstructured":"Toll AD, Dasgupta A, Potoczek M, Yeo CJ, Kleer CG, Brody JR, et al. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. Hum Pathol. 2010;41(9):1205\u20139.","journal-title":"Hum Pathol"},{"issue":"6907","key":"536_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624\u20139.","journal-title":"Nature"},{"issue":"2","key":"536_CR9","first-page":"349","volume":"16","author":"S Weikert","year":"2005","unstructured":"Weikert S, Christoph F, K\u00f6llermann J, M\u00fcller M, Schrader M, Miller K, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med. 2005;16(2):349\u201353.","journal-title":"Int J Mol Med"},{"issue":"11","key":"536_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/pin.12001","volume":"62","author":"HW Lee","year":"2012","unstructured":"Lee HW, Choe M. Expression of EZH2 in renal cell carcinoma as a novel prognostic marker. Pathol Int. 2012;62(11):735\u201341.","journal-title":"Pathol Int"},{"issue":"9","key":"536_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/sj.bjc.6602531","volume":"92","author":"T Sudo","year":"2005","unstructured":"Sudo T, Utsunomiya T, Mimori K, Nagahara H, Ogawa K, Inoue H, et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer. 2005;92(9):1754\u20138.","journal-title":"Br J Cancer"},{"issue":"6","key":"536_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1389203716666150409100233","volume":"16","author":"C Han Li","year":"2015","unstructured":"Han Li C, Chen Y. Targeting EZH2 for cancer therapy: progress and perspective. Curr Protein Pept Sci. 2015;16(6):559\u201370.","journal-title":"Curr Protein Pept Sci"},{"issue":"11","key":"536_CR13","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2217\/epi-2018-0096","volume":"10","author":"S Fattahi","year":"2018","unstructured":"Fattahi S, Golpour M, Amjadi-Moheb F, Sharifi-Pasandi M, Khodadadi P, Pilehchian-Langroudi M, et al. DNA methyltransferases and gastric cancer: insight into targeted therapy. Epigenomics. 2018;10(11):1477\u201397.","journal-title":"Epigenomics"},{"issue":"8","key":"536_CR14","first-page":"2989","volume":"33","author":"A Gnyszka","year":"2013","unstructured":"Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013;33(8):2989\u201396.","journal-title":"Anticancer Res"},{"issue":"8","key":"536_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s10620-007-0145-2","volume":"53","author":"WJ Ding","year":"2008","unstructured":"Ding WJ, Fang JY, Chen XY, Peng YS. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci. 2008;53(8):2083\u20139.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"536_CR16","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.7314\/APJCP.2012.13.7.3173","volume":"13","author":"LJ He","year":"2012","unstructured":"He LJ, Cai MY, Xu GL, Li JJ, Weng ZJ, Xu DZ, et al. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer. Asian Pac J Cancer Prev. 2012;13(7):3173\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"536_CR17","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/0008-5472.CAN-09-2755","volume":"70","author":"T Niwa","year":"2010","unstructured":"Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70(4):1430\u201340.","journal-title":"Cancer Res"},{"issue":"9","key":"536_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/labinvest.2009.65","volume":"89","author":"J Yamaguchi","year":"2009","unstructured":"Yamaguchi J, Sasaki M, Harada K, Zen Y, Sato Y, Ikeda H, et al. Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin. Lab Investig. 2009;89(9):1018\u201331. https:\/\/doi.org\/10.1038\/labinvest.2009.65.","journal-title":"Lab Investig"},{"issue":"2","key":"536_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1349-7006.2009.01387.x","volume":"101","author":"J Yamaguchi","year":"2010","unstructured":"Yamaguchi J, Sasaki M, Sato Y, Itatsu K, Harada K, Zen Y, et al. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma. Cancer Sci. 2010;101(2):355\u201362.","journal-title":"Cancer Sci"},{"issue":"8","key":"536_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.prp.2011.05.010","volume":"207","author":"DC Liu","year":"2011","unstructured":"Liu DC, Yang ZL. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract. 2011;207(8):472\u20138.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"536_CR21","first-page":"8180","volume":"17","author":"B Lin","year":"2018","unstructured":"Lin B, Hong H, Jiang X, Li C, Zhu S, Tang N, et al. c-Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer. Mol Med Rep. 2018;17(6):8180\u20138.","journal-title":"Mol Med Rep"},{"issue":"4","key":"536_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12029-010-9156-x","volume":"41","author":"K Srivastava","year":"2010","unstructured":"Srivastava K, Srivastava A, Mittal B. DNMT3B-579 G > T promoter polymorphism and risk of gallbladder carcinoma in North Indian population. J Gastrointest Cancer. 2010;41(4):248\u201353.","journal-title":"J Gastrointest Cancer"},{"issue":"12","key":"536_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/15257770.2018.1498516","volume":"37","author":"RJ Honeywell","year":"2018","unstructured":"Honeywell RJ, Sarkisjan D, Kristensen MH, de Klerk DJ, Peters GJ. DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors. Nucleosides Nucleotides Nucleic Acids. 2018;37(12):696\u2013708.","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00536-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:19:48Z","timestamp":1634181588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00536-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00536-3","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"6 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}